TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year Current Ratio History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Current Ratio(x) | 2.51 | 4.18 | 1.41 |
What is the latest Current Ratio ratio of TRIDENT LIFELINE ?
Year | Current Ratio |
---|---|
Mar2024 | 2.51 |
Mar2023 | 4.18 |
Mar2022 | 1.41 |
How is Current Ratio of TRIDENT LIFELINE Trending?
Years | Current Ratio | % Change | |
---|---|---|---|
Mar2024 | 2.51 | -39.95 | |
Mar2023 | 4.18 | 196.45 | |
Mar2022 | 1.41 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Quick Ratio Interest Cover Total Debt/Mcap |
Compare Current Ratio ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹331.2 Cr | 2% | 5.7% | 75.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 2% |
5.7% |
75.6% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses